(Q24317730)

amyloid-beta metabolic process

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author name string

Kun Zou

1

0 references

Tomoji Maeda

2

0 references

Atsushi Watanabe

3

0 references

Junjun Liu

4

0 references

Shuyu Liu

5

0 references

Ryutaro Oba

6

0 references

Yoh-ichi Satoh

7

0 references

Hiroto Komano

8

0 references

Makoto Michikawa

Journal of Biological Chemistry

9

0 references

language of work or name

English

0 references

publication date

13 November 2009

0 references

published in

0 references

volume

284

0 references

page(s)

31914-20

0 references

issue

46

0 references

cites work

The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797262

Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797262

Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797262

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797262

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797262

Angiotensin-converting enzyme as a potential target for treatment of Alzheimer's disease: inhibition or activation?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797262

Novel role of presenilins in maturation and transport of integrin beta 1.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797262

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797262

Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797262

Abeta42 is essential for parenchymal and vascular amyloid deposition in mice

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797262

A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797262

The angiotensin-converting enzyme gene family: genomics and pharmacology

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797262

Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797262

Different glycosylation requirements for the synthesis of enzymatically active angiotensin-converting enzyme in mammalian cells and yeast

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797262

Alzheimer disease risk and genetic variation in ACE: a meta-analysis

27 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.011437

Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.011437

Amyloid beta-protein (Abeta)1-40 protects neurons from damage induced by Abeta1-42 in culture and in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.011437

Abeta40 inhibits amyloid deposition in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.011437

The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.011437

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.011437

Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.011437

Role of the N-terminal Catalytic Domain of Angiotensin-converting Enzyme Investigated by Targeted Inactivation in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.011437

15-year longitudinal study of blood pressure and dementia

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19773553

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19773553

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1074/JBC.M109.011437

1 reference

release_tj65ausddrezzhuva3rw36ncju

1112903

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tj65ausddrezzhuva3rw36ncju

mapped directly with Wikidata item

24 November 2022

based on heuristic

1112903

1 reference

1 reference

1 reference